Integrins and their accessory adhesion molecules in mammary carcinomas: loss of polarization in poorly differentiated tumors.
about
The direct binding of insulin-like growth factor-1 (IGF-1) to integrin alphavbeta3 is involved in IGF-1 signalingUrokinase-receptor/integrin complexes are functionally involved in adhesion and progression of human breast cancer in vivoEvaluation of the use of therapeutic peptides for cancer treatmentN-nitroso-N-ethylurea activates DNA damage surveillance pathways and induces transformation in mammalian cells.VEGF-integrin interplay controls tumor growth and vascularization.Integrins: a role as cell signalling molecules.Expression order of alpha-v and beta-3 integrin subunits in the N-methyl-N-nitrosourea-induced rat mammary tumor model.Interstitial guidance of cancer invasion.Integrin activation controls metastasis in human breast cancerCell adhesion molecules in oesophageal epithelium.Cell adhesion molecules and oral cancer.Breast tumor microenvironment: proteomics highlights the treatments targeting secretome.Tumor-specific expression of alphavbeta3 integrin promotes spontaneous metastasis of breast cancer to bone.A triple-targeted ultrasound contrast agent provides improved localization to tumor vasculatureE-cadherin distribution in interleukin 6-induced cell-cell separation of ductal breast carcinoma cellsActivated integrin alphavbeta3 cooperates with metalloproteinase MMP-9 in regulating migration of metastatic breast cancer cellsIntegrin expression in esophageal squamous cell carcinoma: loss of the physiological integrin expression pattern correlates with disease progressionInvolvement of alpha6beta4 integrin in the mechanisms that regulate breast cancer progression.The integrin alpha 6 beta 1 promotes the survival of metastatic human breast carcinoma cells in miceAdhesion systems in normal breast and in invasive breast carcinoma.Expression of hemidesmosomes and component proteins is lost by invasive breast cancer cells.A monoclonal antibody directed against a human cell membrane antigen prevents cell substrate adhesion and tumor invasion.β1-integrins signaling and mammary tumor progression in transgenic mouse models: implications for human breast cancer.Loss of cell-cell and cell-matrix adhesion molecules in colorectal cancer.Clinical significance of the integrin α6β4 in human malignancies.MDM2 overexpression is rare in ovarian carcinoma irrespective of TP53 mutation status.Regulation of keratin and integrin gene expression in cancer and drug resistance.Expression of alphav integrins and vitronectin receptor identity in breast cancer cellsCorrelation between the tumoral expression of beta3-integrin and outcome in cervical cancer patients who had undergone radiotherapybeta1 integrin as a molecular therapeutic target.Instant immunity through chemically programmable vaccination and covalent self-assembly.Activation of tumor cell integrin alphavbeta3 controls angiogenesis and metastatic growth in the brain.Expression of gelatinase A and TIMP-2 mRNAs in desmoplastic fibroblasts in both mammary carcinomas and basal cell carcinomas of the skin.99mTc-labeled cystine knot peptide targeting integrin αvβ6 for tumor SPECT imaging.Detection of integrins in formalin-fixed, paraffin-embedded tissues.A novel dual-targeted ultrasound contrast agent provides improvement of gene delivery efficiency in vitro.An apoptosis-related gene network induced by novel compound-cRGD in human breast cancer cells.Current concepts in metastasis.Adhesion of aspirated tumor cells to extracellular matrix proteins: a new methodology utilizing fine-needle aspiration.Biological indices in the assessment of breast cancer.
P2860
Q24310890-0EEBB755-5151-4B70-A269-BDF6D6F54482Q28350698-0936069B-AFF3-45B7-92BF-F360D74B99A7Q29048586-15E318C9-D87C-4B51-BBFC-CD97695F4869Q30413046-8ED91511-DCC2-4584-9DDD-8CA9C055CED2Q33821325-14625317-4B0B-450A-938A-FBDDDC3F4479Q33850089-D659E9D9-A44B-45BA-B6A5-759B8097AD12Q33904357-B2CB4220-3A5B-466A-A9D1-3570615A74B9Q34029050-EA18B96E-4A06-448A-8FDF-3221A8F112B7Q34107054-FCC8706F-5419-476F-AD34-4E11F74B584FQ34379677-307B0CFB-288A-4BEB-9B1B-A41B82D17334Q34503793-60861CD5-DA7D-4A3E-A858-ECF24ABBF27BQ34759911-C08940C9-4D55-4887-BDD3-8780DA47CA3DQ35012766-BCDD3EDE-47F5-49E0-8ABB-4D3597C3DF34Q35118263-7BF41E01-4D54-4C26-B1AA-05372D3526A0Q35228257-F5F2CC39-7EAB-4560-8CAA-DB4961C20DBCQ35234791-08C840A4-3B90-4C6B-9FCD-936AB5ACF828Q35421768-EAEB920E-F320-4A0F-8983-1CEB9CB133C3Q35749387-CC27B508-7A07-441E-A20D-A23D7C098D7FQ35764011-6BB78115-960C-49E1-B6BB-47DA9CCE221BQ35794930-44617323-58D5-4DF2-8AD8-8FE27B28DFD8Q35796514-414678AD-7FC1-49BF-9B06-B3B2A3C81F88Q35833341-AD42D444-BADC-4943-BC4C-6D7E69D4D0A1Q35889538-831CDAFE-2E17-41C6-A254-D11789511661Q35976571-BED4114F-49E7-46A6-B230-CC296AFBDAACQ36010634-2EB64223-C210-4999-A8B8-64FA8442C612Q36081688-3DCC74CC-48BF-455D-9388-0ADA204CDBDCQ36254808-66EA1989-FCDF-4CD5-AF00-82B44CE0A37EQ36291700-509CCE0C-E65C-44E1-9437-1496C00DAA1BQ36615716-63F72E5F-5B47-4340-8B84-5BD576B9F86CQ37024021-E6D8F99C-8AB8-4EF3-9DC9-D902075F44EFQ37114234-1BBDC893-9A93-40B8-9486-44C9611A98A6Q37229261-CF009BA9-ECD1-480F-86A3-B0EDDA6F342EQ37234490-4150F78C-1587-47EB-A988-C0E73C998783Q37714107-9746D5AC-F43B-4294-BF12-CE4BA978C39FQ38474847-C46ED2C1-AB61-433E-BBED-F35789DF1497Q39608614-95610772-ED43-4FB7-9B8B-2E155303CF4FQ40108509-0CD2901C-A1CA-4E11-8532-520834CFCF32Q40690731-3961E8B0-F10F-4E9E-885C-FE584C653758Q40766857-225D01C9-488E-48E0-BA43-A4FF6B817EE0Q40848953-BAD2222D-A724-4B3A-A179-C96236DDB4F8
P2860
Integrins and their accessory adhesion molecules in mammary carcinomas: loss of polarization in poorly differentiated tumors.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh-hant
name
Integrins and their accessory ...... poorly differentiated tumors.
@en
Integrins and their accessory ...... poorly differentiated tumors.
@nl
type
label
Integrins and their accessory ...... poorly differentiated tumors.
@en
Integrins and their accessory ...... poorly differentiated tumors.
@nl
prefLabel
Integrins and their accessory ...... poorly differentiated tumors.
@en
Integrins and their accessory ...... poorly differentiated tumors.
@nl
P2093
P1433
P1476
Integrins and their accessory ...... poorly differentiated tumors.
@en
P2093
P304
P356
10.1016/0046-8177(92)90034-Z
P407
P577
1992-10-01T00:00:00Z